Insider · CIK 0001644087

Donovan Joanne M.

Reports to the SEC for 2 companies · BOULDER, CO

sec.gov

Transactions

Companies

Filings

CIK

0001644087

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-13	EWTXEdgewise Therapeutics, Inc.S Sale	CMO	SSale	−2,919 sh	$43.41	−$127K	8,625
2026-08-12	EWTXEdgewise Therapeutics, Inc.M Exercise/Conversion	CMO	MExercise/Conversion	+5,781 sh	—	—	11,035
2026-08-12	EWTXEdgewise Therapeutics, Inc. · Stock Option (Right to Buy)A Award	CMO	AAward	+65K sh	—	—	65,000
2026-08-12	EWTXEdgewise Therapeutics, Inc. · Stock Option (Right to Buy)A Award	CMO	AAward	+65K sh	—	—	65,000
2026-08-12	EWTXEdgewise Therapeutics, Inc. · Restricted Stock UnitsA Award	CMO	AAward	+32.5K sh	—	—	32,500
2026-08-12	EWTXEdgewise Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	CMO	MExercise/Conversion	−7,031 sh	—	—	21,094
2026-08-12	EWTXEdgewise Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	CMO	MExercise/Conversion	−5,781 sh	—	—	11,563
2026-08-12	EWTXEdgewise Therapeutics, Inc.S Sale	CMO	SSale	−800 sh	$44.52	−$35.6K	11,544
2026-08-12	EWTXEdgewise Therapeutics, Inc.S Sale	CMO	SSale	−104 sh	$44.43	−$4,620.231	12,344
2026-08-12	EWTXEdgewise Therapeutics, Inc.S Sale	CMO	SSale	−2,779 sh	$43.71	−$121K	12,448
2026-08-12	EWTXEdgewise Therapeutics, Inc.S Sale	CMO	SSale	−2,839 sh	$43.78	−$124K	15,227
2026-08-12	EWTXEdgewise Therapeutics, Inc.M Exercise/Conversion	CMO	MExercise/Conversion	+7,031 sh	—	—	18,066
2026-05-05	EWTXEdgewise Therapeutics, Inc.S Sale	CMO	SSale	−50K sh	$38.57	−$1.93M	4,367
2026-05-05	EWTXEdgewise Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CMO	MExercise/Conversion	−50K sh	—	—	75,000
2026-05-05	EWTXEdgewise Therapeutics, Inc.M Exercise/Conversion	CMO	MExercise/Conversion	+50K sh	$7.08	+$354K	54,367
2026-05-04	EWTXEdgewise Therapeutics, Inc.S Sale	CMO	SSale	−5,230 sh	$31.29	−$164K	4,367
2026-04-01	EWTXEdgewise Therapeutics, Inc.M Exercise/Conversion	CMO	MExercise/Conversion	+28.7K sh	$7.08	+$203K	38,259
2026-04-01	EWTXEdgewise Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CMO	MExercise/Conversion	−28.7K sh	—	—	125,000
2026-04-01	EWTXEdgewise Therapeutics, Inc.S Sale	CMO	SSale	−28.7K sh	$32.31	−$926K	9,597
2026-03-31	EWTXEdgewise Therapeutics, Inc.M Exercise/Conversion	CMO	MExercise/Conversion	+21.3K sh	$7.08	+$151K	30,935
2026-03-31	EWTXEdgewise Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CMO	MExercise/Conversion	−21.3K sh	—	—	153,662
2026-03-31	EWTXEdgewise Therapeutics, Inc.S Sale	CMO	SSale	−21.3K sh	$32.12	−$685K	9,597
2026-03-27	EWTXEdgewise Therapeutics, Inc.S Sale	CMO	SSale	−9,623 sh	$30.98	−$298K	16,332
2026-03-27	EWTXEdgewise Therapeutics, Inc.S Sale	CMO	SSale	−6,735 sh	$30.98	−$209K	9,597
2025-08-12	EWTXEdgewise Therapeutics, Inc. · Stock Option (Right to Buy)A Award	CMO	AAward	+169K sh	—	—	168,750
2025-08-12	EWTXEdgewise Therapeutics, Inc. · Restricted Stock UnitsA Award	CMO	AAward	+28.1K sh	—	—	28,125
2025-08-12	EWTXEdgewise Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	CMO	MExercise/Conversion	−5,781 sh	—	—	17,344
2025-08-12	EWTXEdgewise Therapeutics, Inc.S Sale	CMO	SSale	−2,862 sh	$13.39	−$38.3K	25,361
2025-08-12	EWTXEdgewise Therapeutics, Inc.M Exercise/Conversion	CMO	MExercise/Conversion	+5,781 sh	—	—	28,223
2025-05-02	EWTXEdgewise Therapeutics, Inc.S Sale	CMO	SSale	−5,187 sh	$16.45	−$85.3K	21,588
2025-05-01	EWTXEdgewise Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	CMO	MExercise/Conversion	−10.4K sh	—	—	0
2025-05-01	EWTXEdgewise Therapeutics, Inc.M Exercise/Conversion	CMO	MExercise/Conversion	+10.4K sh	—	—	26,775
2025-01-28	EWTXEdgewise Therapeutics, Inc.M Exercise/Conversion	CMO	MExercise/Conversion	+25K sh	$7.08	+$177K	41,358
2025-01-28	EWTXEdgewise Therapeutics, Inc.S Sale	CMO	SSale	−25K sh	$27.63	−$691K	16,358
2025-01-28	EWTXEdgewise Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CMO	MExercise/Conversion	−25K sh	—	—	175,000
2024-09-20	EWTXEdgewise Therapeutics, Inc.S Sale	CMO	SSale	−7,162 sh	$28.29	−$203K	14,538
2024-08-12	EWTXEdgewise Therapeutics, Inc. · Stock Option (Right to Buy)A Award	CMO	AAward	+139K sh	—	—	138,750
2024-08-12	EWTXEdgewise Therapeutics, Inc. · Restricted Stock UnitsA Award	CMO	AAward	+23.1K sh	—	—	23,125
2024-05-02	EWTXEdgewise Therapeutics, Inc.S Sale	CMO	SSale	−3,682 sh	$18.91	−$69.6K	19,897
2024-05-01	EWTXEdgewise Therapeutics, Inc.M Exercise/Conversion	CMO	MExercise/Conversion	+10.4K sh	—	—	23,579
2024-05-01	EWTXEdgewise Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	CMO	MExercise/Conversion	−10.4K sh	—	—	10,417
2023-08-17	EWTXEdgewise Therapeutics, Inc. · Stock Option (Right to Buy)A Award	CMO	AAward	+200K sh	—	—	200,000
2023-05-02	EWTXEdgewise Therapeutics, Inc.S Sale	CMO	SSale	−3,254 sh	$8.90	−$29K	9,960
2023-05-01	EWTXEdgewise Therapeutics, Inc.M Exercise/Conversion	CMO	MExercise/Conversion	+10.4K sh	—	—	13,214
2023-05-01	EWTXEdgewise Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	CMO	MExercise/Conversion	−10.4K sh	—	—	20,834
2022-08-08	EWTXEdgewise Therapeutics, Inc. · Stock Option (Right to Buy)A Award	CMO	AAward	+240K sh	—	—	240,000
2022-05-01	EWTXEdgewise Therapeutics, Inc. · Restricted Stock UnitsA Award	CMO	AAward	+31.3K sh	—	—	31,250
2021-08-17	EWTXEdgewise Therapeutics, Inc. · Stock Option (Right to Buy)A Award	CMO	AAward	+160K sh	—	—	160,000
2021-04-30	EWTXEdgewise Therapeutics, Inc. · Stock Option (Right to Buy)A Award	CMO	AAward	+160K sh	—	—	160,000
2020-02-12	ATXSAstria Therapeutics, Inc. · Stock Option (right to buy)A Award	CMO; SVP Clinical Development	AAward	+60K sh	—	—	60,000

Recent filings

Accepted (ET)
Aug 174/A
Donovan Joanne M.0001644087-26-000006
SEC(opens sec.gov)
Aug 144
Donovan Joanne M.0001644087-26-000005
SEC(opens sec.gov)
May 54
Donovan Joanne M.0001644087-26-000004
SEC(opens sec.gov)
Apr 24
Donovan Joanne M.0001644087-26-000003
SEC(opens sec.gov)
Mar 314
Donovan Joanne M.0001644087-26-000002
SEC(opens sec.gov)

Companies

Address

C/O EDGEWISE THERAPEUTICS, INC. 1715 38TH STREET

BOULDER, CO, 80301